Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer
Phase I Study of Platinum-based Chemoradiotherapy (CRT) With Oral Rigosertib in Patients With Intermediate or High-risk Head and Neck Squamous Cell Carcinoma
Status: Enrolling
Updated:  6/22/2017
University of Colorado Cancer Center
mi
from
Aurora, CO
Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer
Phase I Study of Platinum-based Chemoradiotherapy (CRT) With Oral Rigosertib in Patients With Intermediate or High-risk Head and Neck Squamous Cell Carcinoma
Status: Enrolling
Updated: 6/22/2017
University of Colorado Cancer Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer
Phase I Study of Platinum-based Chemoradiotherapy (CRT) With Oral Rigosertib in Patients With Intermediate or High-risk Head and Neck Squamous Cell Carcinoma
Status: Enrolling
Updated:  6/22/2017
Montefiore Medical Center
mi
from
The Bronx, NY
Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer
Phase I Study of Platinum-based Chemoradiotherapy (CRT) With Oral Rigosertib in Patients With Intermediate or High-risk Head and Neck Squamous Cell Carcinoma
Status: Enrolling
Updated: 6/22/2017
Montefiore Medical Center
mi
from
The Bronx, NY
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
Kaiser Permanente
mi
from
Los Angeles, CA
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
Kaiser Permanente
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
The University of California Irvine
mi
from
Orange, CA
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
The University of California Irvine
mi
from
Orange, CA
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
University of California at San Francisco
mi
from
San Francisco, CA
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
University of South Florida
mi
from
Tampa, FL
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
Cleveland Clinic Florida
mi
from
Weston, FL
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
Cleveland Clinic Florida
mi
from
Weston, FL
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
Indiana University
mi
from
Indianapolis, IN
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
Ochsner Clinic
mi
from
New Orleans, LA
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
Ochsner Clinic
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
Johns Hopkins
mi
from
Baltimore, MD
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
Massachusetts General Hospital
mi
from
Boston, MA
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
Sunrise Hospital and Medical Center
mi
from
Las Vegas, NV
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
Sunrise Hospital and Medical Center
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
Mount Sinai Beth Israel
mi
from
New York, NY
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
Mount Sinai Beth Israel
mi
from
New York, NY
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
Mount Sinai Hospital
mi
from
New York, NY
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
Cleveland Clinic
mi
from
Cleveland, OH
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
Baylor University Medical Center
mi
from
Dallas, TX
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
Methodist Hospital
mi
from
Houston, TX
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
John Muir Medical Center - Concord Campus
mi
from
Concord, CA
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
John Muir Medical Center - Concord Campus
mi
from
Concord, CA
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
Rush University Medical Center
mi
from
Chicago, IL
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
Barnes Jewish Medical Center
mi
from
Saint Louis, MO
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
Barnes Jewish Medical Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
Weill-Cornell Medical College
mi
from
New York, NY
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
The Christ Hospital
mi
from
Cincinnati, OH
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
The Christ Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
University Hospitals of Cleveland Medical Center
mi
from
Cleveland, OH
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
University Hospitals of Cleveland Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
Medical University of South Carolina
mi
from
Charleston, SC
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated:  6/22/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
A Randomized, Controlled, Parallel, Multicenter Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Enrolling
Updated: 6/22/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Whole-Brain Radiation Therapy and Pemetrexed in Treating Patients With Brain Metastases From Non-Small Cell Lung Cancer
A Phase II Study of Treatment of Brain Metastases From Non-Small Cell Lung Cancer With Concurrent Whole Brain Radiation Therapy and Pemetrexed
Status: Enrolling
Updated:  6/22/2017
Alamance Oncology/Hematology Associates, LLP
mi
from
Burlington, NC
Whole-Brain Radiation Therapy and Pemetrexed in Treating Patients With Brain Metastases From Non-Small Cell Lung Cancer
A Phase II Study of Treatment of Brain Metastases From Non-Small Cell Lung Cancer With Concurrent Whole Brain Radiation Therapy and Pemetrexed
Status: Enrolling
Updated: 6/22/2017
Alamance Oncology/Hematology Associates, LLP
mi
from
Burlington, NC
Click here to add this to my saved trials
Whole-Brain Radiation Therapy and Pemetrexed in Treating Patients With Brain Metastases From Non-Small Cell Lung Cancer
A Phase II Study of Treatment of Brain Metastases From Non-Small Cell Lung Cancer With Concurrent Whole Brain Radiation Therapy and Pemetrexed
Status: Enrolling
Updated:  6/22/2017
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
mi
from
Chapel Hill, NC
Whole-Brain Radiation Therapy and Pemetrexed in Treating Patients With Brain Metastases From Non-Small Cell Lung Cancer
A Phase II Study of Treatment of Brain Metastases From Non-Small Cell Lung Cancer With Concurrent Whole Brain Radiation Therapy and Pemetrexed
Status: Enrolling
Updated: 6/22/2017
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Safety Study of ON 01910.Na in Combination With Irinotecan or Oxaliplatin
A Phase 1 Dose-Escalation Study of the Safety and Clinical Effects of ON 01910.Na in Combination With Either Irinotecan or Oxaliplatin in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  6/22/2017
Albert Einstein Cancer Center
mi
from
The Bronx, NY
Safety Study of ON 01910.Na in Combination With Irinotecan or Oxaliplatin
A Phase 1 Dose-Escalation Study of the Safety and Clinical Effects of ON 01910.Na in Combination With Either Irinotecan or Oxaliplatin in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 6/22/2017
Albert Einstein Cancer Center
mi
from
The Bronx, NY
Click here to add this to my saved trials
Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma
A Phase 1 Dose-Escalation Study of the Safety and Clinical Effects of ON 01910.Na in Combination With Either Irinotecan or Oxaliplatin in Patients With Hepatoma and Other Advanced Solid Tumors
Status: Enrolling
Updated:  6/22/2017
Mount Sinai Hospital
mi
from
New York, NY
Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma
A Phase 1 Dose-Escalation Study of the Safety and Clinical Effects of ON 01910.Na in Combination With Either Irinotecan or Oxaliplatin in Patients With Hepatoma and Other Advanced Solid Tumors
Status: Enrolling
Updated: 6/22/2017
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of 5-day Dosing of ON 01910.Na in Intermediate-1,-2, or High Risk Myelodysplastic Syndrome (MDS)
A Phase 1/2, Single-Arm Study To Assess The Efficacy and Safety Of 5-day Continuous Intravenous Dosing Of ON 01910.Na Administered Every 2 Weeks in Patients With Intermediate-1, Intermediate-2, or High Risk Myelodysplastic Syndrome (MDS)
Status: Enrolling
Updated:  6/22/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Efficacy and Safety of 5-day Dosing of ON 01910.Na in Intermediate-1,-2, or High Risk Myelodysplastic Syndrome (MDS)
A Phase 1/2, Single-Arm Study To Assess The Efficacy and Safety Of 5-day Continuous Intravenous Dosing Of ON 01910.Na Administered Every 2 Weeks in Patients With Intermediate-1, Intermediate-2, or High Risk Myelodysplastic Syndrome (MDS)
Status: Enrolling
Updated: 6/22/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid Tumors
Phase I Dose Escalation Study of Gemcitabine and 24 Hour Infusion of ON 01910.Na in Patients With Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated:  6/22/2017
Department of Medicine, University of California San Francisco
mi
from
San Francisco, CA
Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid Tumors
Phase I Dose Escalation Study of Gemcitabine and 24 Hour Infusion of ON 01910.Na in Patients With Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated: 6/22/2017
Department of Medicine, University of California San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid Tumors
Phase I Dose Escalation Study of Gemcitabine and 24 Hour Infusion of ON 01910.Na in Patients With Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated:  6/22/2017
Albert Einstein Cancer Center/Montefiore Medical Center
mi
from
The Bronx, NY
Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid Tumors
Phase I Dose Escalation Study of Gemcitabine and 24 Hour Infusion of ON 01910.Na in Patients With Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated: 6/22/2017
Albert Einstein Cancer Center/Montefiore Medical Center
mi
from
The Bronx, NY
Click here to add this to my saved trials
Safety of ON 01910.Na as a 3-day Infusion in Patients With Advanced Cancer
Phase I Dose Escalation Study of ON 01910.Na by 3-day Continuous Infusion in Patients With Advanced Cancer
Status: Enrolling
Updated:  6/22/2017
Mount Sinai School of Medicine
mi
from
New York, NY
Safety of ON 01910.Na as a 3-day Infusion in Patients With Advanced Cancer
Phase I Dose Escalation Study of ON 01910.Na by 3-day Continuous Infusion in Patients With Advanced Cancer
Status: Enrolling
Updated: 6/22/2017
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Safety of 24-Hour Infusion of ON 01910.Na in Patients With Advanced Cancer
Phase I Dose Escalation Study of ON 01910.Na by 24 Hour Continuous Infusion Per Week in Patients With Advanced Cancer
Status: Enrolling
Updated:  6/22/2017
Albert Einstein Cancer Center
mi
from
The Bronx, NY
Safety of 24-Hour Infusion of ON 01910.Na in Patients With Advanced Cancer
Phase I Dose Escalation Study of ON 01910.Na by 24 Hour Continuous Infusion Per Week in Patients With Advanced Cancer
Status: Enrolling
Updated: 6/22/2017
Albert Einstein Cancer Center
mi
from
The Bronx, NY
Click here to add this to my saved trials
Refametinib (BAY86-9766) in Combination With Regorafenib (Stivarga, BAY73-4506) in Patients With Advanced or Metastatic Cancer
A Phase 1b/2, Multi-center, Uncontrolled, Open-label, Dose Escalation Study of Refametinib (BAY86-9766) in Combination With Regorafenib (BAY73-4506) in Patients With Advanced or Metastatic Cancer
Status: Enrolling
Updated:  6/25/2017
Clinical Research Facility
mi
from
New Haven, CT
Refametinib (BAY86-9766) in Combination With Regorafenib (Stivarga, BAY73-4506) in Patients With Advanced or Metastatic Cancer
A Phase 1b/2, Multi-center, Uncontrolled, Open-label, Dose Escalation Study of Refametinib (BAY86-9766) in Combination With Regorafenib (BAY73-4506) in Patients With Advanced or Metastatic Cancer
Status: Enrolling
Updated: 6/25/2017
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Refametinib (BAY86-9766) in Combination With Regorafenib (Stivarga, BAY73-4506) in Patients With Advanced or Metastatic Cancer
A Phase 1b/2, Multi-center, Uncontrolled, Open-label, Dose Escalation Study of Refametinib (BAY86-9766) in Combination With Regorafenib (BAY73-4506) in Patients With Advanced or Metastatic Cancer
Status: Enrolling
Updated:  6/25/2017
Clinical Research Facility
mi
from
Detroit, MI
Refametinib (BAY86-9766) in Combination With Regorafenib (Stivarga, BAY73-4506) in Patients With Advanced or Metastatic Cancer
A Phase 1b/2, Multi-center, Uncontrolled, Open-label, Dose Escalation Study of Refametinib (BAY86-9766) in Combination With Regorafenib (BAY73-4506) in Patients With Advanced or Metastatic Cancer
Status: Enrolling
Updated: 6/25/2017
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Refametinib (BAY86-9766) in Combination With Regorafenib (Stivarga, BAY73-4506) in Patients With Advanced or Metastatic Cancer
A Phase 1b/2, Multi-center, Uncontrolled, Open-label, Dose Escalation Study of Refametinib (BAY86-9766) in Combination With Regorafenib (BAY73-4506) in Patients With Advanced or Metastatic Cancer
Status: Enrolling
Updated:  6/25/2017
Clinical Research Facility
mi
from
Chapel Hill, NC
Refametinib (BAY86-9766) in Combination With Regorafenib (Stivarga, BAY73-4506) in Patients With Advanced or Metastatic Cancer
A Phase 1b/2, Multi-center, Uncontrolled, Open-label, Dose Escalation Study of Refametinib (BAY86-9766) in Combination With Regorafenib (BAY73-4506) in Patients With Advanced or Metastatic Cancer
Status: Enrolling
Updated: 6/25/2017
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Refametinib (BAY86-9766) in Combination With Regorafenib (Stivarga, BAY73-4506) in Patients With Advanced or Metastatic Cancer
A Phase 1b/2, Multi-center, Uncontrolled, Open-label, Dose Escalation Study of Refametinib (BAY86-9766) in Combination With Regorafenib (BAY73-4506) in Patients With Advanced or Metastatic Cancer
Status: Enrolling
Updated:  6/25/2017
Clinical Research Facility
mi
from
Houston, TX
Refametinib (BAY86-9766) in Combination With Regorafenib (Stivarga, BAY73-4506) in Patients With Advanced or Metastatic Cancer
A Phase 1b/2, Multi-center, Uncontrolled, Open-label, Dose Escalation Study of Refametinib (BAY86-9766) in Combination With Regorafenib (BAY73-4506) in Patients With Advanced or Metastatic Cancer
Status: Enrolling
Updated: 6/25/2017
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Refametinib (BAY86-9766) in Combination With Regorafenib (Stivarga, BAY73-4506) in Patients With Advanced or Metastatic Cancer
A Phase 1b/2, Multi-center, Uncontrolled, Open-label, Dose Escalation Study of Refametinib (BAY86-9766) in Combination With Regorafenib (BAY73-4506) in Patients With Advanced or Metastatic Cancer
Status: Enrolling
Updated:  6/25/2017
Clinical Research Facility
mi
from
Saint Louis, MO
Refametinib (BAY86-9766) in Combination With Regorafenib (Stivarga, BAY73-4506) in Patients With Advanced or Metastatic Cancer
A Phase 1b/2, Multi-center, Uncontrolled, Open-label, Dose Escalation Study of Refametinib (BAY86-9766) in Combination With Regorafenib (BAY73-4506) in Patients With Advanced or Metastatic Cancer
Status: Enrolling
Updated: 6/25/2017
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Simultaneous Care: Linking Palliation to Clinical Trials
A Randomized Control Trial That Teaches Oncology Clinical Trial Patients and Their Caregivers Problem Solving Skills.
Status: Enrolling
Updated:  6/26/2017
UC Davis Cancer Center
mi
from
Sacramento, CA
Simultaneous Care: Linking Palliation to Clinical Trials
A Randomized Control Trial That Teaches Oncology Clinical Trial Patients and Their Caregivers Problem Solving Skills.
Status: Enrolling
Updated: 6/26/2017
UC Davis Cancer Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
Valley Medical Oncology Consultants - Castro Valley
mi
from
Castro Valley, CA
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Valley Medical Oncology Consultants - Castro Valley
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
East Bay Radiation Oncology Center
mi
from
Castro Valley, CA
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
East Bay Radiation Oncology Center
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
Valley Medical Oncology
mi
from
Fremont, CA
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Valley Medical Oncology
mi
from
Fremont, CA
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
Contra Costa Regional Medical Center
mi
from
Martinez, CA
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Contra Costa Regional Medical Center
mi
from
Martinez, CA
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
El Camino Hospital Cancer Center
mi
from
Mountain View, CA
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
El Camino Hospital Cancer Center
mi
from
Mountain View, CA
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
Bay Area Breast Surgeons, Incorporated
mi
from
Oakland, CA
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Bay Area Breast Surgeons, Incorporated
mi
from
Oakland, CA
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
CCOP - Bay Area Tumor Institute
mi
from
Oakland, CA
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
CCOP - Bay Area Tumor Institute
mi
from
Oakland, CA
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
Tom K Lee, Incorporated
mi
from
Oakland, CA
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Tom K Lee, Incorporated
mi
from
Oakland, CA
Click here to add this to my saved trials
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated:  6/26/2017
Alta Bates Summit Medical Center - Summit Campus
mi
from
Oakland, CA
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Status: Enrolling
Updated: 6/26/2017
Alta Bates Summit Medical Center - Summit Campus
mi
from
Oakland, CA
Click here to add this to my saved trials